Data / Drug companies / Terazosin hydrochloride
Terazosin hydrochloride: 15 companies and 60 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Terazosin hydrochloride is listed in the FDA National Drug Code Directory by 15 companies, with 60 products in commercial distribution. 60 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, and the newest product started marketing on August 7, 2026.
The request: Get every company that lists terazosin hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 60
- Generic (ANDA) products
- 60 (100.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Terazosin
- openFDA record search
- api.fda.gov
Companies that list terazosin hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | 11 | capsule | Generic drugs (ANDA) | June 30, 2020 |
| Amerisyn LLC | 8 | capsule | Generic drugs (ANDA) | August 7, 2026 |
| A-S Medication Solutions | 4 | capsule | Generic drugs (ANDA) | December 20, 2004 |
| Amici Pharma, Inc. | 4 | capsule | Generic drugs (ANDA) | May 20, 2026 |
| Apnar Pharma LP | 4 | capsule | Generic drugs (ANDA) | August 7, 2026 |
| AvKARE | 4 | capsule | Generic drugs (ANDA) | March 30, 2020 |
| AvPAK | 4 | capsule | Generic drugs (ANDA) | February 13, 2020 |
| Bryant Ranch Prepack | 4 | capsule | Generic drugs (ANDA) | December 20, 2004 |
| Jubilant Cadista Pharmaceuticals Inc. | 4 | capsule | Generic drugs (ANDA) | December 20, 2004 |
| Bryant Ranch Prepack | 3 | capsule | Generic drugs (ANDA) | December 20, 2004 |
| Preferred Pharmaceuticals Inc. | 3 | capsule | Generic drugs (ANDA) | April 5, 2012 |
| Remedyrepack Inc. | 3 | capsule | Generic drugs (ANDA) | March 20, 2017 |
| Proficient Rx LP | 2 | capsule | Generic drugs (ANDA) | December 21, 2004 |
| Coupler LLC | 1 | capsule | Generic drugs (ANDA) | December 16, 2025 |
| NuCare Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | December 20, 2004 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 60 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 60 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| alpha-Adrenergic Blocker | 60 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.